Venetoclax is a medication used to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or acute myeloid leukemia.

How Venetoclax works?
Venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL). Venclyxto in combination with rituximab is indicated for the treatment of adult patients with CLL who have received at least one prior therapy.
Common side effects of Venetoclax
diarrhea, constipation, nausea, vomiting, decreased appetite, extreme, tiredness, swelling of your arms or hands, back pain, bone, muscle, or joint pain, abdominal pain, swelling or sores in the mouth
How should I take Venetoclax ?
You should take Venetoclax exactly as directed by your doctor. It should be started by doctors who have experience in administering cancer medicines. Take it once a day with or without food. Do not drink grapefruit juice or eat grapefruit during your treatment with Venetoclax, as the chances of side effects may be more.
What should I do if I forget a dose?
If you miss a dose of Venetoclax by less than 12 hours, take the missed dose as soon as you remember it and then take the next dose at the scheduled time. However, if you miss a dose by more than 12 hours, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
In case of emergency/overdose
In case of overdose, call the poison control helpline. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call a doctor.

Contact Us

    Venetoclax is used to treat some kinds of chronic lymphocytic leukaemia and small lymphocytic lymphoma, either alone or in combination with obinutuzumab (Gazyva) or rituximab (Rituxan). It's also used in combination with azacitidine (Vidaza), decitabine (Dacogen), or cytarabine as a first-line treatment for acute myeloid leukaemia (AML; a cancer that starts in the white blood cells) in people 75 and up, or in adults with medical conditions that prevent them from receiving other chemotherapy medications.
    Venetoclax belongs to a group of drugs known as B-cell lymphoma-2 (BCL-2) inhibitors. It works by preventing a protein in the body from assisting cancer cells in their survival. This aids in the killing of cancer cells.


    The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.

    Enquiry Now
    Translate »

    Want Information?